dynalabs.us - DVx™ General FAQs

DVx™ General FAQs - DYNALABS

Dynalabs.us Spined HTML

DVx™UnstipulatedFAQs - DYNALABS 888.396.2522 314.241.3962 888.396.2522   •   314.241.3962   •   info@dynalabs.us LOGIN User Registration Account Registration  Menu Close Login User Registration Account Registration Products & Services Lab Services State-of-the-art tampering testing laboratory provides data you need to run your business. On Site Testing Less than 4 seconds to objectively verify drug identity and strength in your facility. CQI Program Use our expert knowledge of the pharmaceutical industry to help you grow your business. Continuous Quality Improvement (CQI) Consulting ServicesConsumerImprovement SystemConsumerProduction System Data Analytics Laboratory Services Test Services Lab Services API (Active Pharmaceutical Ingredient ) list DVx™ On site Drug Verification DVx™ Specifications DVx™ Validation Process DVx™UnstipulatedFAQs On-site Managed Services Consulting Improvement Systems Production System Six Step Approach DYNALABS OOS Process Online Services Sample SubmissionConsumerService What We DoHospital Pharmacies Stability of Drug Diversion of Drug In House Training Product Validation Drug Investigation Compounding Pharmacies People: Training Validation Program Materials: Vendor Qualification Program Equipment: Performance Validation Program Process: Process Validation Program Product: Product Validation Program Frequently Asked Questions CompanyOur Story Announcements Announcing a new National Accounts Manager, Christine Versichele. DYNALABS announces new Chief Technology Officer DYNALABS welcomes a new Principal Consultant DYNALABS embarks on $1.2 million expansion DYNALABS Announces a New Vice President of Sales DYNALABS announces Director of Quality & Regulatory Affairs DYNALABS LLC Named One of Inc. 5000 Fastest-Growing Private Companies in 2017 DYNALABS named to the 50 Fastest Growing Companies of 2017 DYNALABS Enhances Antimicrobial Effectiveness Testing for USP Potency Testing for Oxytocin DYNALABS Announces New President DYNALABS investment doubles the size of its testing facility Custom Packing Slip DYNALABS Receives ISO/IEC 17025 Accreditation Entrepreneurial Success SmallMerchantryof the Year 2016 DYNALABS investment doubles the size of its testing facility Enforcing FDA Labeling Policies Entrepreneurial Success Award Events Registrations and Awards Vision, Mission Leadership Partners and Alliances Investor Information ResourcesWebinars Blogs Industry News FDA to Remove APIs from list FDA Drug Shortages The Pharma Reports The Pharma Report | Sept 2018 Tech Bulletin | June 2018 Tech Bulletin | May 2018 Tech Bulletin | April 2018 Tech Bulletin | March 2018 Tech Bulletin | February 2018 Tech Bulletin | January 2018 Tech Bulletin | December 2017 Careers Contact < Home | Products & Services | DVx™ On site Drug Verification | DVx™UnstipulatedFAQs DVx™UnstipulatedFAQs 1. What are the major differences between the DVx-03 and the DVx – 04? The DVx – 04 is a new generation test device that adds spare functions to our previous generation of DVx. Some wide features are: —Analyzes a waif of material (2 µL) in wing to cuvettes (0.5mL) —Provides results faster (less than 4 seconds) from a cloud-based wringer system 2.What types of testing/analysis does the DVx support? The DVx-04 provides identity and concentration testing. 3. Can the DVx-04 be used for stability testing? The DVx-04 is not a stability indicating method. It can be used for a one-time concentration test, but you should not be releasing products solely on this test. You should be conducting spare tests as well. 4. What level of user expertise is required to operate theDVx-04? The DVx-04 is very easy to use. Almost anyone can operate the device. However, only a pharmacy technician, nurse, or a pharmacist should be running tests on the DVx-04. 5. What are the major advantages of the DVx – 04 over other spectrophotometers? With the DVx -04: —Both concentration and identity are provided —Sample data is placid and aggregated over time – trending and wringer will modernize with time and utilization —DYNALABS does its own method development. —The DVx-04 is backed up by the DYNALABS cadre lab facilities 6. What are the costs? We will have an in-depth discussion with you well-nigh the type of testing program you would like to setup with DYNALABS for the DVx-04. Then we will provide you with a detailed proposal that will include the total forfeit of ownership plan for your testing program. In general, the fees include: —A one-time set up fee —A monthly leasing fee —A DVx support fee —Method minutiae fees (8 methods are included for a one-time stock-still price). 7. How can I wilt a DYNALABS DVx-04 customer? Becoming a DYNALABS DVx-04 consumer is a multi-step process involving a discussion and an onboarding and training process: Register with DYNALABS as a new customer. Go through the new consumer screening process. Provide a list of drugs to be tested using the DVx-04, including formulas for each drug. —DYNALABS will typhoon a proposal for your review and clearance —Once the proposal has been approved, DYNALABS will work with you to develop your own custom testing program and ensure you are trained on the DVx-04. DYNALABS LLC is registered with the U.S. Food and Drug Administration (FDA), DEA and Bureau of Narcotics and Dangerous Drugs licensed, as well as ISO 17025 accredited. The products and services provided by DYNALABS are protected by U.S. Patent Nos. 7,197,405 and 7,660,678. © 2018 DYNALABS LLC. All Rights Reserved. For spare information well-nigh DYNALABS please undeniability 888-396-2522   •   info@dynalabs.usTerms Of Use   •   Privacy Policy   •  ConsumerAgreement